Metropolis Health.

₹1747.8 27.8 | 1.6%

WEBSITE BSE:542650 NSE : METROPOLIS 10 May, 16:01

Market Cap ₹8954 Cr.

Stock P/E 71.7

P/B 8.3

Current Price ₹1747.8

Book Value ₹ 209.6

Face Value 2

52W High ₹1935

Dividend Yield 0.46%

52W Low ₹ 1209.3

Edit Ratio

Metropolis Health. Research see more...

Metropolis Healthcare and the Indian Diagnostic Industry

Overview Inc. Year: 2000Industry: Hospital & Healthcare Services

Metropolis Healthcare Ltd provides diagnostic offerings in India. The organisation offers clinical laboratory testing, and profiles and guide services to patients, smaller labs, nursing houses, and hospitals. It offers diagnostic offerings for oncology, neurology, gynaecology, and nephrology, as well as numerous fitness check-up applications for men, women, senior residents, and teenagers and corporates. The organization's tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. It also offers corporate wellbeing and hospital laboratory solutions, in addition to medical studies services. As of March 31, 2021, the organisation operated 125 medical laboratories, 9,000 pick out-up points, and 498 assisted referral centres. Metropolis Healthcare Ltd was established in 1980 and is based in Mumbai, India.

Metropolis Health. Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Metropolis Health. Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	303	293	306	280	300	285	283	277	309	291
Other Income	6	3	6	3	4	7	1	3	1	2
Total Income	308	296	312	283	305	292	284	280	310	293
Total Expenditure	212	218	231	211	221	215	212	214	234	226
Operating Profit	96	78	81	72	83	77	72	66	76	67
Interest	3	5	6	8	7	6	6	6	6	5
Depreciation	15	17	18	21	22	23	23	21	22	25
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	78	56	56	43	55	48	42	39	48	37
Provision for Tax	19	15	16	9	14	12	8	10	12	10
Profit After Tax	58	41	40	34	40	36	33	29	36	27
Adjustments	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Profit After Adjustments	58	41	40	33	40	36	33	29	35	27
Adjusted Earnings Per Share	11.4	8	7.8	6.5	7.9	7	6.5	5.6	6.9	5.3

Metropolis Health. Profit & Loss

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	455	524	545	647	761	856	998	1228	1148	1160
Other Income	6	22	26	8	8	9	12	20	17	7
Total Income	461	546	570	655	769	865	1010	1248	1166	1167
Total Expenditure	337	388	391	469	557	619	708	883	857	886
Operating Profit	124	158	179	186	212	246	302	366	309	281
Interest	2	2	2	4	4	13	12	25	32	23
Depreciation	21	21	17	19	20	39	46	63	89	91
Exceptional Income / Expenses	0	-8	0	0	0	-25	0	16	0	0
Profit Before Tax	101	128	160	164	187	169	244	293	188	166
Provision for Tax	33	46	53	52	63	41	61	79	44	40
Profit After Tax	68	82	107	112	124	128	183	215	143	125
Adjustments	-7	-8	-6	-8	-3	-0	-0	-1	-1	0
Profit After Adjustments	61	74	102	104	120	127	183	214	143	124
Adjusted Earnings Per Share	11.9	14.8	20.5	21	23.9	25.1	35.8	41.9	27.9	24.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-7%	10%	12%	0%
Operating Profit CAGR	-16%	8%	11%	0%
PAT CAGR	-33%	4%	5%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	29%	-8%	13%	NA%
ROE Average	15%	24%	26%	27%
ROCE Average	20%	32%	36%	38%

Metropolis Health. Balance Sheet

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	361	265	323	415	419	523	707	886	988
Minority's Interest	23	20	21	14	1	2	1	2	2
Borrowings	7	3	0	0	0	0	0	159	29
Other Non-Current Liabilities	2	-2	15	147	142	195	111	334	388
Total Current Liabilities	75	105	152	233	241	210	240	364	303
Total Liabilities	468	391	512	810	803	930	1059	1745	1710
Fixed Assets	153	148	202	207	213	296	343	1059	1121
Other Non-Current Assets	14	18	24	160	169	196	71	231	249
Total Current Assets	302	225	285	443	422	438	645	455	341
Total Assets	468	391	512	810	803	930	1059	1745	1710

Metropolis Health. Cash Flow

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	20	24	27	26	43	51	107	387	66
Cash Flow from Operating Activities	70	88	102	104	90	215	249	253	247
Cash Flow from Investing Activities	-56	91	-86	2	35	-105	62	-738	47
Cash Flow from Financing Activities	-10	-166	-17	-87	-118	-55	-33	163	-292
Net Cash Inflow / Outflow	4	13	-1	19	7	55	278	-322	2
Closing Cash & Cash Equivalent	24	36	26	43	51	107	387	66	69

Metropolis Health. Ratios

#	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	11.88	14.84	20.48	21	23.94	25.15	35.82	41.86	27.9
CEPS(Rs)	17.22	20.65	25.08	26.37	28.63	32.95	44.86	54.31	45.42
DPS(Rs)	0	16.08	10.48	0	13.26	8	8	8	8
Book NAV/Share(Rs)	70.43	53.4	65.11	83.23	82.89	102.99	136.57	170.88	191.54
Core EBITDA Margin(%)	25.84	25.97	28.18	27.58	26.79	27.69	29.04	28.14	25.35
EBIT Margin(%)	22.65	24.74	29.71	25.84	25.05	21.18	25.64	25.92	19.1
Pre Tax Margin(%)	22.18	24.43	29.36	25.29	24.51	19.7	24.48	23.88	16.33
PAT Margin (%)	14.91	15.63	19.69	17.28	16.24	14.89	18.37	17.48	12.49
Cash Profit Margin (%)	19.42	19.55	22.85	20.22	18.88	19.48	22.98	22.62	20.26
ROA(%)	14.48	19.06	23.75	16.93	15.33	14.72	18.43	15.31	8.3
ROE(%)	18.77	26.16	36.47	30.38	29.82	27.21	30.07	27.31	15.46
ROCE(%)	27.47	40.06	54.28	45.22	44.77	37.79	41.6	34.39	19.83
Receivable days	61.1	53.38	52.74	51.03	56.95	56.49	45.94	38.4	40.91
Inventory Days	14.71	12.52	10.64	9.96	11.34	10.76	11.88	13.62	15.21
Payable days	96.48	92.04	100.01	89.12	82.24	114.33	141.56	141.34	142.17
PER(x)	0	0	0	0	0	51.15	62.57	48.66	44.76
Price/Book(x)	0	0	0	0	0	12.49	16.41	11.92	6.52
Dividend Yield(%)	0	0	0	0	0	0.62	0.36	0.39	0.64
EV/Net Sales(x)	-0.01	-0.05	-0.06	-0.08	-0.07	7.36	11.06	8.56	5.56
EV/Core EBITDA(x)	-0.04	-0.17	-0.17	-0.27	-0.25	25.65	36.56	28.75	20.68
Net Sales Growth(%)	0	15.24	3.95	18.81	17.62	12.51	16.53	23.08	-6.52
EBIT Growth(%)	0	25.86	24.85	3.32	14.02	-4.87	41.07	24.42	-31.1
PAT Growth(%)	0	20.84	30.91	4.27	10.52	3.19	43.74	17.09	-33.21
EPS Growth(%)	0	24.89	38.07	2.54	14	5.03	42.43	16.85	-33.34
Debt/Equity(x)	0.04	0.03	0	0	0.04	0	0	0.3	0.08
Current Ratio(x)	4.02	2.15	1.88	1.9	1.75	2.08	2.68	1.25	1.12
Quick Ratio(x)	4.08	2.06	1.78	1.81	1.64	1.97	2.52	1.11	0.98
Interest Cover(x)	47.64	80	83.6	47.17	46.29	14.34	22.13	12.72	6.89
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0.02	0.01

Metropolis Health. Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	49.5	49.79	49.79	49.76	49.76	49.75	49.75	49.74	49.74	49.67
FII	30.06	21.91	23.2	25.57	23.86	25.67	25.66	24.29	21.66	18.9
DII	11.35	16.2	14.5	12.38	13.3	13.64	14.89	16.86	20.73	24.86
Public	9.09	12.11	12.52	12.29	13.08	10.94	9.7	9.11	7.87	6.57
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	2.53	2.55	2.55	2.55	2.55	2.55	2.55	2.55	2.55	2.54
FII	1.54	1.12	1.19	1.31	1.22	1.31	1.31	1.24	1.11	0.97
DII	0.58	0.83	0.74	0.63	0.68	0.7	0.76	0.86	1.06	1.27
Public	0.47	0.62	0.64	0.63	0.67	0.56	0.5	0.47	0.4	0.34
Others	0	0	0	0	0	0	0	0	0	0
Total	5.12	5.12	5.12	5.12	5.12	5.12	5.12	5.12	5.12	5.12

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 24%
Company has reduced debt.
Company is almost debt free.

Cons

Promoter holding is low: 49.67%.
Debtor days have increased from 141.34 to 142.17days.
Stock is trading at 8.3 times its book value.
The company has delivered a poor profit growth of 5% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Metropolis Health. News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Metropolis Health.

Add Watchlist

Metropolis Health. Research see more...

Overview Inc. Year: 2000Industry: Hospital & Healthcare Services

Metropolis Health. Share Price

Alert Data

Quarterly Price

Peer Comparison

Metropolis Health. Quarterly Results

Metropolis Health. Profit & Loss

Growth Rates

Metropolis Health. Balance Sheet

Metropolis Health. Cash Flow

Metropolis Health. Ratios

Metropolis Health. Shareholding Pattern

Metropolis Health. News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!